Search of published and open access research on microarray, sequencing and proteomic expression analyses did not uncover any datasets to evaluate whether TMEM230 was differentially expressed specifically between non-malignant glial cells and glial cells from low- or high-grade gliomas. Here, TMEM230 is linked to glioma.